The overall goals of the CURE: DDRCC Human Studies Core (HSC) are to provide leadership and an infrastructure to enhance clinical and translational research in digestive diseases. This is implemented by providing specific services to CURE investigators with research grants, their trainees, and collaborators. The specific goals of the Human Studies Core are to provide CURE:DDRCC members, trainees, and their collaborators with access to: 1) expert researchers and their staff in clinical, endoscopic, translational, and outcomes research for assistance and advice about cognitive, technical and procedural aspects of these types of gastrointestinal (Gl) research; 2) facilitate utilization of fully equipped and networked endoscopy medical procedure units (MPU's) for GI clinical, physiologic and translational research studies; 3) teaching clinical research techniques and consultation about study design, data management, software options, statistical analysis, and routine outcomes of prospective randomized controlled studies of large multicenter or cooperative trials for diagnosis or treatments in Gl disorders; 4) expertise, utilization, and collaboration with PI'S and their research staff who maintain tissue, cyst fluid, sera and other bio-specimens and HIPAA compliant databases of clinical patients with selected Gl diseases (e.g. obesity, Gl hemorrhage, small bowel disorders, pancreatic pre-cancerous conditions, Barrett's epithelium with and without dysplasia, Gl mucosal inflammatory diseases -AIDS or IBD - and neuroenteric or functional Gl diseases); and 5) expertise and utilization of specialized equipment for Gl intra-luminal studies in collaboration with experts, including deep enteroscopy and capsule endoscopy for small bowel. There are 18 investigators who will utilize these core services at UCLA and VA. This has been a unique and successful core that has provided services in the last 5 years to 20 funded users and 19 pre and post doctoral trainees. This core has facilitated their academic careers by enhancing collaborative research, providing services to develop research results that contributed to funding of several important federal grants, and contributed to significant research publications related to Gl disorders.

Public Health Relevance

Our goals are to improve understanding, knowledge, and treatment of Gl disorders in a cost-effective and collaborative approach. Using patients and human samples to study pathogenesis and treatments increases the relevance to human diseases. The Human Studies Core space, equipment, expertise, and personnel required to provide these services are expensive but are shared for collaborative research with clinical, outcomes and translational researchers and their trainees in a cost-effective way.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK041301-29
Application #
9392153
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
29
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Bonfiglio, Ferdinando; Zheng, Tenghao; Garcia-Etxebarria, Koldo et al. (2018) Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. Gastroenterology 155:168-179
Hoffman, Jill M; Sideri, Aristea; Ruiz, Jonathan J et al. (2018) Mesenteric Adipose-derived Stromal Cells From Crohn's Disease Patients Induce Protective Effects in Colonic Epithelial Cells and Mice With Colitis. Cell Mol Gastroenterol Hepatol 6:1-16
Kageyama, Shoichi; Nakamura, Kojiro; Fujii, Takehiro et al. (2018) Recombinant relaxin protects liver transplants from ischemia damage by hepatocyte glucocorticoid receptor: From bench-to-bedside. Hepatology 68:258-273
Wen, Yi; Scott, David R; Vagin, Olga et al. (2018) Measurement of Internal pH in Helicobacter pylori by Using Green Fluorescent Protein Fluorimetry. J Bacteriol 200:
Koon, Hon Wai; Wang, Jiani; Mussatto, Caroline C et al. (2018) Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-?B Activity. Antimicrob Agents Chemother 62:
Wang, Jiani; Ghali, Sally; Xu, Chunlan et al. (2018) Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Gastroenterology 154:1737-1750
Manatsathit, Wuttiporn; Khrucharoen, Usah; Jensen, Dennis M et al. (2018) Laparotomy and intraoperative enteroscopy for obscure gastrointestinal bleeding before and after the era of video capsule endoscopy and deep enteroscopy: A tertiary center experience. Am J Surg 215:603-609
Rankin, Carl Robert; Theodorou, Evangelos; Man Law, Ivy Ka et al. (2018) Identification of novel mRNAs and lncRNAs associated with mouse experimental colitis and human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 315:G722-G733
Park, S H; Naliboff, B D; Shih, W et al. (2018) Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response. Neurogastroenterol Motil 30:
Dong, Tien; Pisegna, Joseph (2018) Passing the ""Acid Test"": Do Proton Pump Inhibitors Affect the Composition of the Microbiome? Dig Dis Sci :

Showing the most recent 10 out of 1097 publications